Assay Designs snares Stressgen Bioreagents

Assay Designs of Ann Arbor, Michigan, has acquired Canada's Stressgen Bioreagents. Stressgen develops and markets antibodies, proteins and related kits to life sciences researchers worldwide. No financial details were released. Dr. Russell Hart, Assay Designs' co-founder and president, said, "The combination of Assay Designs and Stressgen creates exciting opportunities. For example, it allows us to leverage Stressgen's expertise in heat shock proteins, active kinases and antibodies to develop new, unique kits. We also plan to take advantage of Stressgen's West coast location to extend customer service and technical support coverage for Assay Designs' customers, and vice versa."

- read this press release for more

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.